By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Interferons > Peginterferon beta-1a > Peginterferon beta-1a Side Effects
Interferons

Peginterferon beta-1a Side Effects

Summary

Commonly reported side effects of peginterferon beta-1a include: arthralgia, asthenia, fever, flu-like symptoms, headache, myalgia, chills, erythema at injection site, pain at injection site, and swelling at injection site. Other side effects include: suicidal ideation, hyperthermia, increased serum alanine aminotransferase, pruritus, vomiting, decreased white blood cell count, depression, increased serum aspartate aminotransferase, and increased body temperature. Continue reading for a comprehensive list of adverse effects.

Applies to peginterferon beta-1a: solution.

Serious side effects

Along with its needed effects, peginterferon beta-1a may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking peginterferon beta-1a:

More common

  • Blue-green to black skin discoloration
  • chills
  • cough
  • diarrhea
  • dizziness
  • extremely high fever or body temperature
  • fast, shallow breathing
  • fast, weak heartbeat
  • fever
  • general feeling of discomfort or illness
  • joint pain
  • muscle aches, cramps, and pains
  • pale, clammy skin
  • runny nose
  • seizures
  • shivering
  • sore throat
  • sweating
  • thirst
  • trouble sleeping
  • unusual tiredness or weakness
  • vomiting

Less common

  • Dark urine
  • decreased appetite
  • itching skin
  • light-colored stools
  • stomach pain
  • yellow eyes or skin

Rare

  • Chest tightness
  • difficulty with swallowing
  • hives or welts, skin rash
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals
  • puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
  • redness of the skin

Other side effects

Some side effects of peginterferon beta-1a may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Difficulty with moving
  • itching, rash, redness, soreness, swelling, or warmth at the injection site
  • lack or loss of strength
  • muscle aches, cramps, pains, or stiffness
  • pain, redness, or sloughing of the skin at the injection site

For Healthcare Professionals

Applies to peginterferon beta-1a: intramuscular solution, subcutaneous kit, subcutaneous solution.

Cardiovascular

Frequency not reported: Congestive heart failure[Ref]

Dermatologic

Common (1% to 10%): Pruritus[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, vomiting[Ref]

General

The most common side effects were injection site erythema, influenza-like illness, pyrexia, headache, myalgia, chills, injection site pain, asthenia, injection site pruritus, and arthralgia.[Ref]

Hematologic

Frequency not reported: Decreased peripheral blood counts[Ref]

Hepatic

Common (1% to 10%): Alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyl-transferase increased

Frequency not reported: hepatic injury[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Anaphylaxis, angioedema, urticaria[Ref]

Immunologic

Very common (10% or more): Influenza like illness (47%)

Frequency not reported: Autoimmune disorders[Ref]

Local

Very common (10% or more): Injection site erythema (62%), injection site pain (15%), injection site pruritus (13%)

Common (1% to 10%): Injection site edema, injection site warmth, injection site hematoma, injection site rash[Ref]

Musculoskeletal

Very common (10% or more): Myalgia (19%), arthralgia (11%)[Ref]

Nervous system

Very common (10% or more): Headache (44%)

Uncommon (0.1% to 1%): Seizures[Ref]

Other

Very common (10% or more): Pyrexia (45%), chills (17%), asthenia (13%)

Common (1% to 10%): Hyperthermia, pain[Ref]

Psychiatric

Common (1% to 10%): Depression, suicide[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by